Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Clinical trial NCT07388550 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07388550
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-26
- Primary completion
- 2028-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.